BAY-6672 hydrochloride

• CAT Number: I041196
• CAS Number: 2247520-31-4
• Molecular Formula: C26H28BrCl2N3O3
• Molecular Weight: 581.33
• Purity: ≥95%
• Synonyms: (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid;hydrochloride
• InChI: InChI=1S/C26H27BrClN3O3.ClH/c1-16-24(20-14-18(27)9-10-22(20)30-25(16)31-12-4-5-13-31)26(34)29-15-17(8-11-23(32)33)19-6-2-3-7-21(19)28;/h2-3,6-7,9-10,14,17H,4-5,8,11-13,15H2,1H3,(H,29,34)(H,32,33);1H/t17-;/m0./s1
• InChIKey: GTKCWLJRFBWMPZ-LMOVPXPDSA-N
• SMILES: CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl.Cl

BAY-6672 hydrochloride（Cat No.:I041196）is a small molecule inhibitor developed for its potential in treating cancer and other diseases associated with abnormal cell signaling. It targets specific kinases involved in tumor cell proliferation and survival, aiming to reduce cancer cell growth and induce apoptosis. Preclinical studies have shown that BAY-6672 hydrochloride has potent anti-tumor effects, particularly in cancers resistant to traditional therapies. Ongoing clinical trials are evaluating its safety, efficacy, and potential to be used in combination with other cancer treatments, offering a promising new approach to oncology therapeutics.